Startups channel feed – Endpoints News

Startups channel feed

Five Prime founder Rusty Williams sets out to test the limits of cell therapy with axolotl-inspired biotech

4 years ago

Exclusive: Prison and multibillion dollar buyouts later, Sam Waksal is all in on the biotech game, with some big-name backers

4 years ago

Ionis collaborator Flamingo is ready to take flight with 3 antisense drugs in the clinic and mysterious RNA in its sights

4 years ago

The Tachi Yamada legacy tree continues to grow with a new gene editing biotech from Jim Wilson

4 years ago

'Like a kid in a candy shop': Michael Ehlers gets behind RNA 'copy machine' tech

4 years ago

There's a new anti-aging upstart in town — and it's reportedly backed by Amazon billionaire Jeff Bezos

4 years ago

Roche schizophrenia drug that failed PhIII gets a new life in rare disorder as OrbiMed leads $90M for startup

4 years ago

ARCH-backed George Church spinout shuts down after gene therapy tech struggles in animal models

4 years ago

A Novartis castoff drug gets new life at an Atlas-backed startup looking to blaze a trail in obesity

4 years ago

Former Blueprint and Peloton vets team up to take on big players in growing hunt for a new type of small molecule

4 years ago

We asked our biopharma readers about their company's policies on vaccine mandates. Feelings are running strong

4 years ago

Jeff Bluestone just raised $265M to develop curative cell therapies. We asked him how

4 years ago

Takeda and Frazier team up again to launch a spinout — this time focused on a late-stage vaccine

4 years ago

From cellist to synthetic cell-ist: Jeffrey Kim scores $23M to reimagine blood tests, cell therapy

4 years ago

Can a next-gen take on a deadly weight loss pill conquer cardiometabolic diseases? A Medicxi-backed startup thinks so

4 years ago

Discovery by Shanghai scientists inspires new plan of ATTEC for protein degradation

4 years ago

AI startup Entos looks to one-up the rest of the field by folding quantum mechanics into its discovery platform

4 years ago

David Liu takes the wraps off $315M launch round for Prime Medicine and new CRISPR tech that gave Bob Nelsen a 'holy crap' moment

4 years ago

Startup boasting 'gobstopper-style' vaccine delivery draws big partnerships — and backing from Adjuvant Capital

4 years ago

Scoop: Bob Nelsen is building a Really Big Neuroscience Company

4 years ago

Former Viela CEO Bing Yao finds his next gig — bringing Chinese R&D innovation stateside

4 years ago

Can a small band of biopharma players succeed where Eli Lilly failed? They’re taking a shot

4 years ago

Can a cell therapy treat muscular dystrophy? A German billionaire's anti-aging startup is trying to find out

4 years ago

A pair of former MIT researchers think they've unlocked the next generation of mRNA using synbio 'logic circuits'

4 years ago

First page Previous page 44 45 464748 49 50 Next page Last page